2020 ASCO Update on 1L Treatment of ES-SCLC: IO + Chemo - Results from KEYNOTE-064 Study (Pembro + EP Improve PFS) & CASPIAN Study (Durvalumab + EP new SoC)

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

2020 ASCO Update on 1L Treatment of ES-SCLC: IO + Chemo - Results from KEYNOTE-064 Study (Pembro + EP Improve PFS) & CASPIAN Study (Durvalumab + EP new SoC)

By 2020 ASCO Virtual Direct™ Highlights FEATURING Nagashree Seetharamu

249 views

July 10, 2020

0 Comments

Updates in Small Cell Lung Carcinoma

18:35

2023 Evolution Conference

Recent Updates in SCLC

Feat. S. Kazmi

20:43

GRACE

Newer Types of Treatment for Lung Cancer: ADCs and Bispecifics

Feat. L. Bazhenova

10:49

Niels Reinmuth

CASPIAN Trial: Clinical Implications of a 3-Year OS Update of Durval…

09:19

Total Health

West Cancer Center Updates on SCLC

Feat. J. Porter

17:09

Stanford Medicine

New Drugs for Small Cell Lung Cancer

Feat. M. Das

07:17

Misty Shields

The Importance of Staying on Therapy for SCLC to Achieve Optimal Ben…

22:11

Insights from ELCC 2024

ELCC 2024 Insights: "Recent Advances and Challenges - Non-IO Ap…

Feat. M. Früh

20:30

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "New Therapies for SCLC"

Feat. S. Lau

33:05

Icahn School of Medicine at Mount Sinai

Leveraging SCLC Subtypes and Other Biomarkers

Feat. F. Hirsch

23:38

Weill Cornell Medicine Oncology & Hematology

Radiation Combined With IO for the Treatment of SCLC

Feat. A. Saxena

04:18

Integrity Continuing Education

Advancing Care for Patients With SCLC

Feat. N. Florez, E. Rodriguez, C. Smith

10:16

Jerome Goldschmidt

National Platinum Chemo Shortages: Impact on Lung Cancer Treatment a…

06:45

Insights from 2023 ESMO Asia Annual Meeting

ESMO Asia 2023 Insights: "DeLLphi-301 Study - Tarlatamab for Pa…

Feat. M. Ahn

08:53

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "CASPIAN Study Phase 3 Updates: The Progno…

Feat. A. Ganti

14:25

Alejandro Navarro

Dissecting SKYSCRAPER-02 Trial - TIGIT Story: From Hope to Nihilism

28:49

European School of Oncology

Management of SCLC: Guidelines ESMO & NCCN

Feat. A. Passaro

05:13

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Phase 3 LAGOON Study - Lurbinectedin Al…

Feat. B. Besse

22:21

Total Health

Immunotherapy for SCLC - Best of Lung 2023

Feat. J. Malhotra

12:25

Lowell Hart

Login

Login

Join VuMedi

2020 ASCO Update on 1L Treatment of ES-SCLC: IO + Chemo - Results from KEYNOTE-064 Study (Pembro + EP Improve PFS) & CASPIAN Study (Durvalumab + EP new SoC)

Related Content